Brii Biosciences Balance Sheet Health
Financial Health criteria checks 6/6
Brii Biosciences has a total shareholder equity of CN¥2.8B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.9B and CN¥86.3M respectively.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥2.39b |
| Equity | CN¥2.81b |
| Total liabilities | CN¥86.31m |
| Total assets | CN¥2.90b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7SS's short term assets (CN¥2.6B) exceed its short term liabilities (CN¥67.7M).
Long Term Liabilities: 7SS's short term assets (CN¥2.6B) exceed its long term liabilities (CN¥18.6M).
Debt to Equity History and Analysis
Debt Level: 7SS is debt free.
Reducing Debt: 7SS had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 7SS has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 7SS has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 7.6% each year